Conference Reports for NATAP

Back

11th International Workshop on Clinical Pharmacology of HIV Therapy April 9-7, 2010 Sorrento, Italy     11th International Workshop on Clinical Pharmacology of HIV Therapy (April 2010) Report - written by Courtney V. Fletcher, Pharm.D. Dean and Professor College of Pharmacy University of Nebraska Medical Center - (04/27/10)   Evaluation of Ritonavir-boosted Elvitegravir PK upon Co-administration with a Second Potent CYP3A inhibitor, Ketoconazole - (04/23/10)   Metabolism and Excretion in Humans of the Pharmacoenhancer GS-9350 - (04/22/10)   Relative Bioavailability and Pharmacokinetics of Darunavir when boosted with the Pharmacoenhancer GS-9350 versus Ritonavir - (04/21/10)   GRACE PK Study: Median (range) AUC12h and C0h were similar between women and men, and across black, Hispanic and white patients; Pharmacokinetic results from GRACE demonstrated no clinically relevant differences in exposure to DRV across a range of covariates, including sex, race/ethnicity, use of ETR, use of TDF, age, body weight and hepatitis B co-infection status - (04/13/10)   Pharmacokinetic interaction study between TMC278, a next-generation NNRTI, and methadone - (04/13/10)   Higher Darunavir and Raltegravir Levels in Small Study of People With Liver Disease - written by Mark Mascolini - (04/13/10)   Limited Risk of Serious Interaction Between TMC278 and Methadone - written by Mark Mascolini - (04/13/10)   More Than Half in Barcelona HIV Clinic Use Alternative Therapies - written by Mark Mascolini - (04/13/10)   Cell Levels of Once-Daily Raltegravir Adequate in Pilot Study - written by Mark Mascolini - (04/13/10)   Older Age Impairs Kidney Function During Tenofovir Therapy - written by Mark Mascolini - (04/13/10)   Etravirine Lowers Levels of S/GSK Integrase Inhibitor, But PIs Counter Effect - written by Mark Mascolini - (04/13/10)   Darunavir Boosting with GS-9350 (Cobicistat) or Ritonavir in Healthy Volunteers - written by Mark Mascolini - (04/13/10)   Extra CYP3A Inhibitor Has Modest Impact on Already-Boosted Elvitegravir - written by Mark Mascolini - (04/13/10)   What Will It Take To Replace Ritonavir as the Prime PK Booster? ...Debate Ritonavir v GS9350 - written by Mark Mascolini - (04/13/10)   Higher Atazanavir Levels Sync With Higher Raltegravir Levels in Dual Combo - written by Mark Mascolini - (04/13/10)   The Effect of Food Intake on Reyataz Blood Levels - written by Mark Mascolini - (04/13/10)   Darunavir Levels Not Tied to Detectable HIV RNA in MONET Monotherapy Trial - written by Mark Mascolini - (04/13/10)   Darunavir Levels Not Affected by Gender, Race, or Age in GRACE Trial - written by Mark Mascolini - (04/13/10)   Impact of Pravastatin on Raltegravir Levels in Healthy Volunteers - written by Mark Mascolini - (04/13/10)   Efavirenz Troughs Higher in People Over 50 Years Old - written by Mark Mascolini - (04/13/10)   Women With Tight HIV Control Have Higher Antiretroviral Troughs Than General Population - written by Mark Mascolini - (04/13/10)